Navigation Links
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Date:2/26/2009

ds for the Benelux countries, and Poland for Eastern and Central European countries. Cephalon Europe markets more than 30 products in four areas: central nervous system, pain, primary care and oncology.

The company's proprietary products in the United States include: AMRIX(R) (cyclobenzaprine hydrochloride extended-release capsules), TREANDA(R) (bendamustine hydrochloride) for Injection, FENTORA(R) (fentanyl buccal tablet) [C-II], PROVIGIL(R) (modafinil) Tablets [C-IV], TRISENOX(R) (arsenic trioxide) injection, GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(R) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this announcement may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding the characterizations of Arana's technology platform and patent portfolio, probability of success with respect to TNF compounds, future strength and growth of Cephalon's drug delivery business, anticipated scientific progress on its research programs, development of potential pharmaceutical products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, sales and earnings guidance, and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "estimate," "expect," "project," "intend," "plan," "believe" or other words and terms of similar meaning. Cephalon's performance and fina
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... (HealthDay News) -- The risk of burns from fires ... need to be extra cautious, an expert says. ... significant increase in patients coming in with burns," said ... Volunteer Firefighters Burn Center of Stony Brook University Hospital ... of joy, but if not careful, could quickly turn ...
(Date:12/25/2014)... (HealthDay News) -- Among early stage breast cancer patients ... of one percent will eventually develop leukemia as a ... The finding comes from a review of more than ... and it suggests that the risk for developing treatment-related ... previously thought. "The frequency of bone marrow cancers ...
(Date:12/25/2014)... 2014 AngelWeddingDress.com tries its best to ... realm. Today, the business has introduced its new collection ... dress promotion. , The new prom outfits are guaranteed ... dress lover. They are specially designed for 2015. Anyone ... dresses should visit its website before Jan. 26, 2015, ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch ... and coolest mobile applications on the iOS, Android, and Windows ... NewsWatch, conducted the app review and shared with viewers how ... , The old saying goes, “A picture says a thousand ... can describe a single image, because each picture holds a ...
(Date:12/25/2014)... December 25, 2014 Residents at ... Community, recently showed their generous spirit by providing ... Catawba County Parenting Network- Grandparents Raising Grandchildren program. ... gathered around the largest Christmas tree on the ... purchased by residents of the Abernethy Village Association ...
Breaking Medicine News(10 mins):Health News:Don't Let Burns Mar Your Holidays 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 2Health News:Breast Cancer Chemo Tied to Small But Significant Leukemia Risk 3Health News:Angelweddingdress 2015 Prom Dresses Online Now 2Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Retirement Community Residents Make Impact During Holiday Season 2
... Dialysis Corporation,of America (Nasdaq: DCAI ) ... facility in Delaware County, Ohio which began construction,late ... CEO Stephen Everett commented, "Our newest facility in ... inspections, with zero,deficiencies. The facility is in partnership ...
... of disease up to 60%, researcher says , , MONDAY, ... 10 new genetic variations associated with an increased risk for ... genetic variants that are known to be associated with prostate ... online edition of Nature Genetics . , "Predisposition to ...
... a nonprofit patient advocacy group, today applauded Congress ... a record $10 million in,psoriasis research funding during ... at NIH. Since 1995, NIH funding on other,diseases ... psoriatic,arthritis research had been stuck between $5 and ...
... Living Inc.,(NYSE: BKD ) (the "Company") today announced ... Company,s Board of Directors,effective February 7, 2008. In connection ... position as Co-CEO, and will no longer serve as ... Brookdale,s Co-CEO,will remain as the sole Chief Executive Officer ...
... LCA-Vision Inc. (Nasdaq:,LCAV), a leading provider of laser vision ... and full-year financial and,operational results for the period ended ... Highlights (all comparisons are,versus the fourth quarter of 2006), ... from $56.0 million; adjusted revenue ...
... Can Save Lives and Billions of Dollars, ... from more than 150 countries will begin negotiations,here ... trade in tobacco,products - a massive global problem ... lives, helps fund organized crime and terrorist,organizations, and ...
Cached Medicine News:Health News:Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio 2Health News:More Gene Variations Found That Raise Prostate Cancer Risk 2Health News:More Gene Variations Found That Raise Prostate Cancer Risk 3Health News:Psoriasis Cure Now Applauds Record Government Psoriasis Research Funding 2Health News:Brookdale Senior Living Announces Changes in Senior Management and Board of Directors 2Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 2Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 3Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 4Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 5Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 6Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 7Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 8Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 9Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 10Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 11Health News:LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results 12Health News:Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 2Health News:Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 3Health News:Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 4
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin ... company that specializes in patented biopharmaceutical, modernized traditional ... ingredients (API) today announced that the Company achieved ... Good Manufacturing Practice (GMP) certificate of TPI,s Qionglai ... Administration,s (CFDA). The public notice period is a ...
(Date:12/24/2014)... and RALEIGH, N.C. , ... of Endo International plc (NASDAQ: ENDP ) ... BDSI ) announced today that they have submitted ... Film to the U.S. Food and Drug Administration (FDA).  ... management of pain severe enough to require daily, around-the-clock, ...
(Date:12/22/2014)... JUNCTION, N.J. , Dec. 22, 2014 /PRNewswire/ ... company marketing its CytoSorb® blood purification technology to ... surgery patients in 28 countries worldwide, today announced ... Russo , MD, FACS, as its Senior Vice ... Dr. Di Russo ...
Breaking Medicine Technology:TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
... Michigan, July 19, 2011 ,   ... Health & Services,Collaboration Aims to Improve Overall Interdisciplinary Care , ... Elsevier / CPM Resource Center (CPM), a leader in ... Providence Health & Services, a not-for-profit,health system committed to providing ...
... LLC, an established CRO providing clinical research services in ... the pharmaceutical and biotechnology industry, announced today the opening ... of the United States. (Photo:   ... to its headquarters in San Francisco, CA, ClinStar,s new ...
Cached Medicine Technology:Elsevier CPM Resource Center to Integrate Evidence-Based Clinical Content Software at Providence Health & Services 2Elsevier CPM Resource Center to Integrate Evidence-Based Clinical Content Software at Providence Health & Services 3Elsevier CPM Resource Center to Integrate Evidence-Based Clinical Content Software at Providence Health & Services 4ClinStar, LLC Establishes New Office on the US East Coast 2
Traditional design utility pliers have adjustable jaws. Good all purpose plier for handling Steinmann Pins, K-Wires, screws and rods. 10mm jaw tip....
Delicate side cutting wire cutter with carbide inserts....
8 inch Mayo-Hegar needle holder....
... Camera ,IS2s Single Rectangular Head Camera is ... SPECT studies. Offering flexibility, ease of use and ... Head Camera is an ideal camera for bone ... work, and also acquires excellent cardiac images. Its ...
Medicine Products: